Identification of genomic alterations associated with metastasis and cancer specific survival in clear cell renal cell carcinoma

Journal of Urology

Volumn 186, Issue 5, 2011, Pages 2078-2083

  Sanjmyatav, Jimsgene ^a,b,c   Junker, Kerstin ^a,b,c   Matthes, Sophie ^a,b,c   Muehr, Martin ^a,b,c   Sava, Doriana ^a,b,c   Sternal, Maria ^a,b,c   Wessendorf, Sven ^a,b,c   Kreuz, Markus ^a,b,c   Gajda, Mieczyslaw ^a,b,c   Wunderlich, Heiko ^a,b,c   Schwaenen, Carsten ^a,b,c  

^a JENA UNIVERSITY HOSPITAL   (Germany)

^b UNIVERSITY HOSPITAL ULM   (Germany)

^c Institute for Medical Informatics   (Germany)

Author keywords

carcinoma; fluorescence; genetic markers; in situ hybridization; kidney; prognosis; renal cell

Indexed keywords

ADULT; AGED; ARTICLE; CANCER RECURRENCE; CANCER SURVIVAL; CHROMOSOME 12Q; CHROMOSOME 1Q; CHROMOSOME 20Q; CHROMOSOME 7; CHROMOSOME 9; CHROMOSOME 9P; CHROMOSOME ABERRATION; CLEAR CELL CARCINOMA; COMPARATIVE GENOMIC HYBRIDIZATION; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENOME; HUMAN; HUMAN TISSUE; KAPLAN MEIER METHOD; KIDNEY CARCINOMA; MAJOR CLINICAL STUDY; MALE; METASTASIS; PRIORITY JOURNAL; PROGNOSIS; RECURRENT DISEASE;

CARCINOMA, RENAL CELL; CHROMOSOME ABERRATIONS; COMPARATIVE GENOMIC HYBRIDIZATION; DNA COPY NUMBER VARIATIONS; FEMALE; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; KIDNEY NEOPLASMS; MALE; MULTIVARIATE ANALYSIS; NEOPLASM METASTASIS; PROGNOSIS;

EID: 80053937503     PISSN: 00225347     EISSN: 15273792     Source Type: Journal    
DOI: 10.1016/j.juro.2011.06.050     Document Type: Article

References (30)

1. A. Zisman, A.J. Pantuck, and J. Wieder Risk group assessment and clinical outcome algorithm to predict the natural history of patients with surgically resected renal cell carcinoma J Clin Oncol 20 2002 4559
2. I. Frank, M.L. Blute, and J.C. Cheville An outcome prediction model for patients with clear cell renal cell carcinoma treated with radical nephrectomy based on tumor stage, size, grade and necrosis: the SSIGN score J Urol 168 2002 2395
3. B. Gunawan, W. Huber, and M. Holtrup Prognostic impacts of cytogenetic findings in clear cell renal cell carcinoma: gain of 5q31-qter predicts a distinct clinical phenotype with favorable prognosis Cancer Res 61 2001 7731
4. H. Moch, J.C. Presti Jr, and G. Sauter Genetic aberrations detected by comparative genomic hybridization are associated with clinical outcome in renal cell carcinoma Cancer Res 56 1996 27
5. M. Brunelli, A. Eccher, and S. Gobbo Loss of chromosome 9p is an independent prognostic factor in patients with clear cell renal cell carcinoma Mod Pathol 21 2008 1
6. K. Junker, G. Weirich, and M.B. Amin Genetic subtyping of renal cell carcinoma by comparative genomic hybridization Recent Results Cancer Res 162 2003 169
7. M. Wilhelm, J.A. Veltman, and A.B. Olshen Array-based comparative genomic hybridization for the differential diagnosis of renal cell cancer Cancer Res 62 2002 957
8. A. Szponar, D. Zubakov, and J. Pawlak Three genetic developmental stages of papillary renal cell tumors: duplication of chromosome 1q marks fatal progression Int J Cancer 124 2009 2071
9. C. Schwaenen, M. Nessling, and S. Wessendorf Automated array-based genomic profiling in chronic lymphocytic leukemia: development of a clinical tool and discovery of recurrent genomic alterations Proc Natl Acad Sci USA 101 2004 1039
10. M. Kreuz, M. Rosolowski, and H. Berger Development and implementation of an analysis tool for array-based comparative genomic hybridization Methods Inf Med 46 2007 608
11. J. Sanjmyatav, N. Rubtsov, and H. Starke Identification of tumor entities of renal cell carcinoma using interphase fluorescence in situ hybridization J Urol 174 2005 731
12. T. Yoshimoto, K. Matsuura, and S. Karnan High-resolution analysis of DNA copy number alterations and gene expression in renal clear cell carcinoma J Pathol 213 2007 392
13. K. Junker, P. Moravek, and M. Podhola Genetic alterations in metastatic renal cell carcinoma detected by comparative genomic hybridization: correlation with clinical and histological data Int J Oncol 17 2000 903
14. E. Arai, S. Ushijima, and H. Tsuda Genetic clustering of clear cell renal cell carcinoma based on array-comparative genomic hybridization: its association with DNA methylation alteration and patient outcome Clin Cancer Res 14 2008 5531
15. G. Kovacs, M. Akhtar, and B.J. Beckwith The Heidelberg classification of renal cell tumours J Pathol 183 1997 131
16. R.A. Figlin Renal cell carcinoma: management of advanced disease J Urol 161 1999 381
17. J. Gronwald, S. Storkel, and H. Holtgreve-Grez Comparison of DNA gains and losses in primary renal clear cell carcinomas and metastatic sites: importance of 1q and 3p copy number changes in metastatic events Cancer Res 57 1997 481
18. G.V. Sherbet Metastasis promoter S100A4 is a potentially valuable molecular target for cancer therapy Cancer Lett 280 2009 15
19. S.C. Garrett, K.M. Varney, and D.J. Weber S100A4, a mediator of metastasis J Biol Chem 281 2006 677
20. H.K. Zhou, Y.B. Zhao, and S.B. Zheng Association of S100A4 mRNA expression with differentiation and metastasis of renal cell carcinoma Di Yi Jun Yi Da Xue Xue Bao 25 2005 712
21. E. Hirota, L. Yan, and T. Tsunoda Genome-wide gene expression profiles of clear cell renal cell carcinoma: identification of molecular targets for treatment of renal cell carcinoma Int J Oncol 29 2006 799
22. T. Klatte, P.N. Rao, and M. de Martino Cytogenetic profile predicts prognosis of patients with clear cell renal cell carcinoma J Clin Oncol 27 2009 746
23. N.E. Sharpless, M.R. Ramsey, and P. Balasubramanian The differential impact of p16(INK4a) or p19(ARF) deficiency on cell growth and tumorigenesis Oncogene 23 2004 379
24. S.O. Ikuerowo, M.A. Kuczyk, and R. von Wasielewski p16INK4a expression and clinicopathologic parameters in renal cell carcinoma Eur Urol 51 2007 732
25. Y. Kimura, T. Noguchi, and K. Kawahara Genetic alterations in 102 primary gastric cancers by comparative genomic hybridization: gain of 20q and loss of 18q are associated with tumor progression Mod Pathol 17 2004 1328
26. M.M. Tanner, M. Tirkkonen, and A. Kallioniemi Amplification of chromosomal region 20q13 in invasive breast cancer: prognostic implications Clin Cancer Res 1 1995 1455
27. V. Alla, D. Engelmann, and A. Niemetz E2F1 in melanoma progression and metastasis J Natl Cancer Inst 102 2010 127
28. R. Poincloux, T. Al Saati, and I. Maridonneau-Parini The oncogenic activity of the Src family kinase Hck requires the cooperative action of the plasma membrane- and lysosome-associated isoforms Eur J Cancer 45 2009 321
29. P. Loukopoulos, T. Shibata, and H. Katoh Genome-wide array-based comparative genomic hybridization analysis of pancreatic adenocarcinoma: identification of genetic indicators that predict patient outcome Cancer Sci 98 2007 392
30. P. Peduzzi, J. Concato, and E. Kemper A simulation study of the number of events per variable in logistic regression analysis J Clin Epidemiol 49 1996 1373